CP-320626

• CAT Number: I006208
• CAS Number: 186430-23-9
• Molecular Formula: C23H23ClFN3O3
• Molecular Weight: 443.90
• Purity: ≥95%
• Synonyms: CP-320626; CP320626; CP 320626; UNII-WHL1Z3GN15.;1H-Indole-2-carboxamide, 5-chloro-N-((1S)-1-((4-fluorophenyl)methyl)-2-(4-hydroxy-1-piperidinyl)-2-oxoethyl)-
• Target: LGPa Inhibitor
• Solubility: Soluble in DMSO, not in water
• Storage: 0 - 4°C for short term ,or -20 °C for long term
• IUPAC Name: 5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide
• InChI: InChI=1S/C23H23ClFN3O3/c24-16-3-6-19-15(12-16)13-20(26-19)22(30)27-21(11-14-1-4-17(25)5-2-14)23(31)28-9-7-18(29)8-10-28/h1-6,12-13,18,21,26,29H,7-11H2,(H,27,30)/t21-/m0/s1
• InChIKey: YDCGVASFVACWKF-NRFANRHFSA-N
• SMILES: C1CN(CCC1O)C(=O)[C@H](CC2=CC=C(C=C2)F)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl

CP-320626（Cat No.:I006208）is a selective and potent inhibitor of the enzyme dipeptidyl peptidase IV (DPP-IV), which plays a crucial role in the breakdown of incretin hormones such as GLP-1 and GIP. By inhibiting DPP-IV, CP-320626 increases the levels of these hormones, leading to enhanced insulin secretion and improved blood glucose control. It has been studied for its potential use in treating type 2 diabetes mellitus by improving glycemic control. Research is ongoing to assess its efficacy, safety, and long-term benefits compared to other DPP-IV inhibitors currently available in the market.